Deutsche Bank: $3.4 billion acquisition of Trivium brings multi-channel value; assigns Buy rating to Silgan (SLGN.US)

According to Zhitong Finance APP, the largest M&A deal in the packaging industry this year has been completed. On October 19, U.S. rigid packaging manufacturer Silgan Holdings (SLGN.US) announced it will merge its metal container business and its food and beverage flat cap closure business with Dutch metal packaging company Trivium Packaging to form "Silgan Metal Containers and Closures" (MCC). The consideration for acquiring Trivium is an enterprise value of about $3.4 billion.

Deutsche Bank gave a positive review in a research report on the same day: The $3.4 billion acquisition is just on the surface. In essence, it's a repositioning of Silgan's portfolio—after the deal, shareholders simultaneously face three value channels: MCC's synergy realization, the potential mid- to long-term spin-off of the metal packaging business, and capital redirected towards the faster-growing Dispensing Solutions business.

How the Deal Is Structured: AIP Pays $1 Billion for 40%, Silgan Gets $2.3 Billion Cash to Repay Debt

According to public terms, the sellers of Trivium are the Ontario Teachers’ Pension Plan (OTPP) and Ardagh Group—holding approximately 58% and 42%, respectively. Trivium, headquartered in the Netherlands, produces two-piece and three-piece cans, aerosol cans, and threaded bottles, with revenues of about $3 billion expected in 2025.

The uniqueness lies not just in the purchase, but in how it's being done. Private equity firm American Industrial Partners (AIP) is investing about $1 billion in cash in exchange for 40% of MCC equity; Silgan retains 60% control and will receive about $2.3 billion in cash at closing to repay existing debt. Silgan's own metal containers and closures business, contributed to the deal, is valued at an enterprise value of around $3.8 billion.

In other words, Silgan completed an acquisition as large as itself without spending shareholders’ money, and still netted $2.3 billion in cash.

Acquisition Multiple: 7.1x Is Not Expensive, Only 4.8x After Synergy

Deutsche Bank believes the valuation is the most direct persuasive element of this deal. The $3.4 billion equates to about 7.1x Trivium’s latest twelve months (LTM) adjusted EBITDA; management expects annualized synergies of $225 million, compressing the implied acquisition multiple down to about 4.8x.

For comparison, Silgan's two contributed businesses are valued at about $3.8 billion, representing about 8.1x LTM adjusted EBITDA—buying another business at a lower multiple than valuing your own is rarely seen among similar deals.

The overall guidance from management: The deal is leverage-neutral for Silgan at the consolidated level and is expected to bring at least a 15% increase in adjusted EPS and free cash flow, already factoring in the expected synergies and dilution from AIP’s 40% minority interest. The transaction is expected to close by mid-2027, subject to regulatory approvals, completion of union consultation procedures, and other customary conditions.

$225 Million Synergy: Three-Year Ramp-Up, But Requires $225 Million Upfront Cost

Synergies are the fulcrum of the deal's valuation logic. Management has mapped a path to about $75 million in run-rate synergies in the first year, about $150 million in the second year, and reaching the full $225 million in the third year. Structurally, this is about 50% operational, 30% procurement, and 20% SG&A. Management claims these numbers are based on bottom-up detailed due diligence, with high confidence in scale and timing.

It's important to recognize the cost side: To achieve $225 million in annual recurring savings, management estimates a one-time cost of about $225 million—that is, about 1x the synergistic value. Deutsche Bank specifically highlights this distinction—one-time costs are incurred upfront, while savings, once fully realized, recur annually.

Why Give Up 40%: Not for Financing, But to Pave the Way for a Spin-Off

Deutsche Bank notes that its biggest question before the deal was: Since the acquisition multiple is cheap and the synergies substantial, why would Silgan give AIP 40% of MCC’s economic interest? According to Deutsche Bank, management’s answer during the conference call was one of the deal’s most attractive features.

AIP’s $1 billion equity investment allows Silgan to maintain 60% control without putting up massive shareholder capital, while also keeping consolidated leverage neutral; management also stated that bringing in a partner is a key part of the deal structure—it helps maintain leverage and builds a channel for the eventual spin-off.

On capital structure, MCC is expected to have about $4.9 billion in debt at closing, with run-rate synergies resulting in about 4x leverage; estimated financing costs are about 7% according to current forward curves. The Dispensing Solutions business left within Silgan will start with net leverage of only about 1.8x. Deutsche Bank believes this structure avoids significantly increasing Silgan’s leverage just to acquire Trivium, keeps room for integrated optimization of the metal packaging platform, and enables continued investment in dispensing solutions.

The New Profile of Two Platforms: MCC for Scale, Dispensing for Growth

The merged MCC is projected to have annual sales of about $7.3 billion, adjusted EBITDA of about $1.2 billion (including the full $225 million synergy), a manufacturing network of over 100 factories, and annual output capacity exceeding 27 billion cans and 30 billion closures. Capex is expected to remain around 3% of sales, in line with Silgan’s original metal container business.

Regionally and by product, there’s clear complementarity: Silgan brings its North American food can business and food and beverage flat cap closures; Trivium significantly expands the company’s footprint in Europe and brings exposure to aerosol cans and aluminum beverage bottles. Management emphasized the recent growth in aerosol cans, especially aluminum ones, describing this merger as an opportunity to broaden the product basket for increasingly global clients.

On the other side, Silgan’s existing dispensing systems and custom container business will become "Silgan Dispensing Solutions," with expected annual sales of about $2.5 billion and adjusted EBITDA of about $555 million, equating to a roughly 22% profit margin and starting net leverage of only about 1.8x. The terminal market structure is also more attractive: about half from fragrance, beauty, and personal care; about 20% from home care and gardening; over 10% from healthcare, and the rest from food dispensing. Management projects high single-digit growth for medical/pharmaceutical, mid-single digits for fragrance/beauty/personal care, and low single digits for home care and garden.

Deutsche Bank refers to this business as “potentially the more important part of the story.” Management made clear that M&A remains a strategic component for dispensing solutions, with a robust project pipeline, and the new balance sheet structure provides ample room for organic investment and disciplined acquisitions. In Deutsche Bank’s view, this forms a second upside channel: shareholders also retain exposure to a more focused, well-capitalized specialty packaging platform.

The Spin-Off May Come Earlier Than Three-Year Synergy Timeline

Deutsche Bank notes that the most important incremental information from the call was management's comments on the eventual MCC spin-off.

The initial materials stated that the spin-off would depend on integration progress, synergy realization, business readiness, and market conditions. But in the Q&A, management was more specific: the priority is to integrate the business and realize first-year synergies; once first-year synergies are achieved and management sees a clear path to second-year savings, Silgan will accelerate the spin-off process. This means the spin-off may not need to wait for the full three-year synergy target to be realized.

According to public information, Silgan has already established a path for MCC to become an independent listed company via tax-free distribution; Silgan will hold three of the five new board seats (CEO Adam Greenlee, Anthony J. Allott, and Shawn C. Fabry), with AIP nominating the other two.

Risk: Regulatory Approval Is a Key Variable in the Closing Timeline

Deutsche Bank lists regulatory review as a key transaction risk to monitor. Management acknowledges an overlap between Silgan and Trivium in the food can business but emphasizes changes in the competitive landscape—including competition from alternative packaging and finished product imports, as well as geographic complementarity (Silgan is more exposed in the US, Trivium in Europe)—and highlights Trivium's aerosol can and aluminum beverage bottle business as providing product supplementation. Given the scale of the post-merger platform and the food can overlap, Deutsche Bank considers regulatory review a crucial part of the expected closing timeline.

Another risk lies in execution: Silgan needs to close and integrate a manufacturing network of over 100 plants and deliver the $225 million run-rate synergy target.

Conclusion

Deutsche Bank's overall view is that the risk-reward ratio is attractive: Silgan retains 60% of a larger global metal packaging platform, releases about $2.3 billion in cash, reduces the starting net leverage of the Dispensing Solutions business to about 1.8x, at the expense of increased organizational complexity and significant execution demands. Deutsche Bank maintains a "Buy" rating and a $49 price target.

In the market, Silgan closed at $40.06 on October 19, up 5.98% from $37.80 the previous trading day, marking a contrast to its -18.0% performance over the past three months and -13.2% over the past twelve months.